Pharma

Data image

Past, present and future

Seamless commercial view of the industry

Build your understanding of the commercial issues that affect your strategic investment decisions.
Commercial data

Calibrated commercial data

Transparent aggregation of datasets

We calibrate different datasets to industry standards and proprietary methodologies which is why Evaluate is trusted and used industry-wide.
Data lenses

Breadth and depth

Cut the data exactly as you need

Use any and all of a huge range of data lenses including global, region, drug, company and therapeutic area.

EvaluatePharma:

  • Consensus Forecasts to 2024
  • Historical Sales from 1986
  • Archive Sales Forecasts
  • Sales by Indication
  • Therapeutic Area
  • Orphan Drugs
  • Biosimilars
  • Pharma Class
  • Sales, Volume & Pricing USA, Europe, Japan & Brazil
  • Company Financials

  • Portfolio Analysis
  • Patent Risk
  • Pipeline Freshness Index
  • Venture Financing & IPO
  • M&A Analysis
  • Company Profiles
  • Daily news and Vantage
  • Drug Profiles
  • Tracking Drugs @FDA
  • Approvals EMEA
  • Uptake Curves
  • Expedited Approvals

  • Licensing Deals
  • Event Analyzer
  • R&D Pipeline
  • Peer Group Analyzer
  • Merge Company
  • Customised reporting and easy export
  • Integrate reports into workflows via plugins

EvaluatePharma Vision:

  • The full EvaluatePharma solution plus:
  • Clinical Trials
  • Success Rates
  • R&D Costs
  • Outcomes
  • Timelines
  • Calendar of Events
  • NPV Analyzer

Evaluate is not a package I can do without... It's an absolute timesaver, and if you're saving time you're saving money.

ANTHONY M, SENIOR DIRECTOR, COMPETITIVE INTELLIGENCE & PROSPECTION, NOVARTIS

Evaluate makes it possible for us to assess the commercial value for different products, as well as understand the major trends in the pharmaceutical industry.

Dr. HIROHISA NAKADA, ASSOCIATE DIRECTOR, BUSINESS DEVELOPMENT, OTSUKA HOLDINGS